Istuntosali

Government bills13

Topicreimbursements for medicine expenses13
  1. HE 111/2025 vpPassed with amendments

    Medicine savings and deregulating self-care medicines

    Prices of prescription medicines and pharmacies' gross margins will be cut, and the basis for determining the pharmacy tax will be reformed. At the same time, certain low-risk self-care medicines will be permitted for sale outside pharmacies and pharmacies will be given the right to deviate from prescriptions in situations of availability disruptions.

    18 Dec 2025 · 12 votes
    90 jaa
    79 ei
  2. HE 129/2024 vpPassed with amendments

    Raising initial deductible for medicine reimbursements

    The annual initial deductible for prescription medicine reimbursements will increase from 50 euros to 70 euros from the beginning of 2025 and will in future be tied to the national pension index. At the same time, pharmacies will be required to keep in stock and always offer customers the lowest-priced medicine option.

    9 Dec 2024 · 3 votes

    Closest vote · Lausumaehdotus, mietintö / Hanna-Leena Mattila

    103 jaa
    79 ei
  3. HE 236/2022 vpPassed

    Strengthening family benefits and purchasing power

    Several social benefits for families with children will be increased for 2023 due to accelerating inflation and rising prices. In addition, the annual out-of-pocket maximum for medicine reimbursements will be frozen for one year, and the care supplement of the private day care allowance will be increased permanently.

    7 Dec 2022 · passed without a vote
  4. HE 57/2023 vpPassed

    Limiting the medicine ceiling increase

    The increase in the annual out-of-pocket maximum for medicine expenses, or the medicine ceiling, will be limited from the start of 2024. The change prevents index increases from accumulating into a single year as a result of the 2023 freeze.

    29 Nov 2023 · 1 vote

    Only vote · 8 §, mietintö / Ilmari Nurminen

    86 jaa
    68 ei
  5. HE 314/2022 vpPassed with amendments

    Introducing pharmacy substitution for biological medicines

    Pharmacies will be required to substitute expensive biological medicines with cheaper equivalents, known as biosimilars. At the same time, biological medicines will be brought within the reference price system for medicine reimbursements to reduce medicine costs.

    21 Feb 2023 · passed without a vote
  6. HE 245/2022 vpPassed with amendments

    Lowering medicine costs and reimbursement expenditure

    Medicine prices and state medicine reimbursement expenditure will be reduced by obliging doctors to prescribe the most affordable biological medicines and by expanding generic substitution for asthma medicines in pharmacies. In addition, pharmacy sales margins on expensive prescription medicines will be cut and pharmacy tax will be reduced.

    13 Dec 2022 · 2 votes

    Closest vote · Lausumaehdotus, mietintö / Terhi Koulumies

    99 jaa
    72 ei
  7. HE 184/2016 vpPassed

    Medicine reimbursement cuts and price competition

    Savings of 134 million euros will be targeted at medicine reimbursements by increasing price competition between medicines and reducing medicine wastage. At the same time, the reimbursement rate for diabetes medicines other than insulin will be reduced, and the quantity of expensive medicines reimbursed at one time will be decreased.

    2 Dec 2016 · 2 votes
    144 jaa
    29 ei
  8. HE 160/2018 vpPassed with amendments

    Freezing national pension index-linked benefits

    Index increases to social benefits tied to the national pension index, such as the national pension and unemployment benefits, will be foregone in 2019. However, the basic amount of social assistance will be increased in line with rising prices.

    20 Dec 2018 · 8 votes
    97 jaa
    84 ei
  9. HE 106/2015 vpPassed with amendments

    Cutting health insurance reimbursements and copayments

    Health insurance reimbursements for medicines, travel and medical care will be cut, and the copayments paid by clients will be increased. In addition, temporary additional fees will be imposed on operators in the pharmaceutical sector for 2016.

    22 Dec 2015 · 5 votes
    114 jaa
    71 ei
  10. HE 40/2019 vpPassed

    Extending conditional reimbursement for new medicines

    Conditional Kela reimbursement for new and expensive medicines will be extended until the end of 2025. In addition, the rules on medicine reimbursements and entrepreneurs' occupational healthcare reimbursements will be clarified.

    29 Nov 2019 · passed without a vote
  11. HE 206/2018 vpPassed with amendments

    Improving basic security and parental allowances

    The minimum sickness and parental allowances, rehabilitation allowances and the guarantee pension will be increased, and the annual ceiling on medicine expenses will be lowered. At the same time, the rights of single parents, adoptive parents and multiple-birth families to parental allowances will be improved.

    20 Dec 2018 · 19 votes

    Closest vote · 3. lakiehdotus, 35 §, mietintö / Anneli Kiljunen

    96 jaa
    87 ei
  12. HE 123/2017 vpPassed with amendments

    Freezing 2018 social benefit index increases

    Social benefits linked to the national pension index will not be increased in 2018, but will remain at their 2017 level. However, a separate increase matching price increases will be made to the basic amount of social assistance, and the level of veterans' benefits will be maintained.

    13 Dec 2017 · 4 votes
    106 jaa
    77 ei
  13. HE 128/2015 vpPassed with amendments

    Halving medicine reimbursement savings in 2016

    Planned savings in medicine reimbursements for 2016 would be reduced from 50 million euros to 25 million euros. The savings would be divided equally between increases in medicine users' copayments and fees levied on pharmaceutical sector businesses.

    15 Dec 2015 · passed without a vote